What is ILMN's five-year median EV/EBITDA?

18.9x. Half of ILMN's weekly readings since July 2025 were higher and half were lower. This page has 121 weekly readings, from Jul 1, 2024 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares ILMN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Illumina Inc (ILMN) valuation history

Health Care

$269.42

Latest weekly close · Market cap $41.2B

Historically high

As of Oct 24, 2026

ILMN's EV/EBITDA of 35.1x is higher than 95% of its weekly readings since July 2025.

Weekly EV/EBITDA since July 2025

EV/EBITDA each weekMiddle half of its readingsMedian 18.9×

Median: 18.9×
Low to high: 8.7×–36.3×
Versus median: +86%
History starts: July 2025

EV/EBITDA

95thpercentile

of its weekly readings since July 2025

Historically high

Growth, last 12 months vs the year before

Revenue: +5%accelerating
EPS: -32%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

ILMN EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	19.4×	Too little history
Dec 30, 2024	n/a	Too little history

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare ILMN with peers

Health Care peers of ILMN on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
AAgilent Technologies	26.9×	Historically high	91
AVTRAvantor Inc	128.7×	Historically high	100
BIOBio-Rad Laboratories Inc	n/a	Not ranked	n/a, not ranked
BRKRBruker Corp	52.1×	Historically high	97
CRLCharles River Laboratories	48.3×	Historically high	100

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on ILMN

No articles about ILMN yet. How valuation percentiles work

Loading peers and related research…

About this history

What is ILMN's current EV/EBITDA?: ILMN's EV/EBITDA of 35.1x is higher than 95% of its weekly readings since July 2025.
What is ILMN's five-year median EV/EBITDA?: 18.9x. Half of ILMN's weekly readings since July 2025 were higher and half were lower. This page has 121 weekly readings, from Jul 1, 2024 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares ILMN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.